Fig. 1From: CAFs targeted ultrasound-responsive nanodroplets loaded V9302 and GLULsiRNA to inhibit melanoma growth via glutamine metabolic reprogramming and tumor microenvironment remodelingSchematic diagram illustrating antitumor effects by combining of UTMD and FH-V9302-siGLUL-NDs to cancer cells and CAFsBack to article page